you are here:
Success
Alert
Please select a Day.
Info
299.45
-2.50 (-0.83%)

As on 22 Jun, 2021 | 03:31

Trade
Day Range
292.00
307.95
L H
52 Week Range
135.00
318.00
L H
Volume
6,641
*
i

* BSE Market Depth (22 Jun 2021)

BUY SELL
QTY PRICE PRICE QTY
50 295.15 300.00 190
20 294.30 307.50 25
219 294.00 307.80 25
10 293.00 308.00 100
50 292.65 308.90 5
354 Total Total 633
Bid / Ask
295.15 / 300.00
300.00
-2.00 (-0.66%)

As on 22 Jun, 2021 | 04:00

Day Range
294.00
308.90
L H
52 Week Range
130.05
321.90
L H
Volume
1,182
*
i

* BSE Market Depth (22 Jun 2021)

BUY SELL
QTY PRICE PRICE QTY
50 295.15 300.00 190
20 294.30 307.50 25
219 294.00 307.80 25
10 293.00 308.00 100
50 292.65 308.90 5
354 Total Total 633
Bid / Ask
295.15 / 300.00
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open307.95
          Previous Close301.95
          UC Limit317.00
          LC Limit286.90
          Volume6,641.00
          VWAP300.62
          Mkt Cap (Rs. Cr.)396
          20D Avg Volume12,634
          20D Avg Delivery32,888
          Beta0.390.64
          Face Value10.00
          TTM EPS4.90
          TTM PE61.11
          Sector PE94.26
          Book Value Per Share243.05
          P/B1.24
          Dividend Yield0.00
          P/C14.16

          Advanced Chart

          Click here to expand

          *Delayed by 20 seconds.

          MC Insights

          Mid-range performer: Stock with medium financial performance with average price momentum and valuation. These stocks may be affordable and are showing some investors interest.

          Price
          • Bullish Momentum - Above Short, Medium and Long Term Moving Averages
          • 121.81% away from 52 week low
          • 6.97% away from 52 week high
          • Outperformer - Artemis Medicare Services Limi up by 10.72% v/s NIFTY 50 up by 3.94% in last 1 month
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          4

          indicates Weak Financials

          3 year CAGR growth
          Revenue -
          NetProfit %
          OperatingProfit %
          Industry Comparison
          • TTM PE Ratio - Above industry Median
          • Market Cap - Above industry Median
          • Price to Book Ratio - Below industry Median
          • TTM PEG Ratio - Negative PEG TTM PE to Growth
          Shareholding Pattern
          • Promoters holding remains unchanged at 69.82% in Mar 2021 qtr
          • Institutional Investors holding remains unchanged at 8.59% in Mar 2021 qtr

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          Forum

          Community Sentiments

          Data not Available

          What's your call on today?

          Read 3 investor views

          BUY SELL HOLD

          Broker Research

          No Data For Broker Research.

          Deals

          No Data For Block Deals.

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          No Data For Bulk Deals.

          Insider Transaction Summary

          No Data For Insider Transaction Summary.

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          No Data For Substantial Acquisition of Shares & Takeovers.

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity
          • Revenue
          • Net Profit
          • EPS
          • BVPS
          • ROE
          • Debt to Equity

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE(%) 1 Yr Perform(%) Net Profit(Rs.) Net Sales(Rs.) Debt to Equity
          AMSL 299.45 -0.83 396.40 61.11 1.23 2.02 60.13 6 408 0.34
          Apollo Hospital 3,258.20 0.62 46,847.92 232.07 13.50 13.62 133.01 434 11,246 1.00
          Dr Lal PathLab 3,138.35 -0.43 26,156.54 89.69 20.50 23.42 100.18 296 1,581 0.00
          Max Healthcare 249.60 1.30 24,109.99 - 11.14 -2.43 - -114 2,504 0.16
          Fortis Health 232.00 -1.34 17,515.03 - 2.61 -1.79 91.34 -103 4,030 0.23

          About the Company

          Data is not Available
          {"success":1,"data":{"address":{"address1":"Plot No. 14,\n","address2":"Sector 20,,\nDwarka,","city":"Delhi","state":"Delhi","pincode":"110075","telephone1":"0124-6767999","telephone2":"","fax1":"0124-","fax2":"","email":"investor@artemishospitals.com","web":"http:\/\/www.artemishospitals.com"},"management":[{"name":"Onkar S Kanwar","designation":"Chairman & Non-Exe.Director"},{"name":"Devlina Chakravarty","designation":"Managing Director"},{"name":"Shalini Kanwar Chand","designation":"Non Executive Director"},{"name":"Neeraj Kanwar","designation":"Non Executive Director"},{"name":"Nirmal Kumar Ganguly","designation":"Non Executive Director"}],"registrars":{"name":"Alankit Assignment Ltd.","address1":"1E\/13, Alankit Heights,\nJhandewalan Extension","address2":"","address3":"","address4":"","telephone":"011-42541234, 42541960","fax":"011-23552001","email":"rta@alankit.com","internet":"http:\/\/www.alankit.com","city":"New Delhi","state":"Delhi","pincode":"110055"},"listing":[{"name":"BSE 100","value":"No"},{"name":"BSE 200","value":"No"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"No"}],"details":{"bseId":"542919","nseId":"ARTEMISMED","series":"BE","isinid":"INE025R01013"}}}
          • Registered Office

          • Registrars

            • Address

              1E/13, Alankit Heights, Jhandewalan Extension,

            • City

              New Delhi 110055

            • State

              Delhi

            • Tel. No.

              011-42541234, 42541960

            • Fax No.

              011-23552001

            • Email

              rta@alankit.com

            • Internet

              http://www.alankit.com

          • Management

            • Onkar S Kanwar

              Chairman & Non-Exe.Director

            • Devlina Chakravarty

              Managing Director

            • Shalini Kanwar Chand

              Non Executive Director

            • Neeraj Kanwar

              Non Executive Director

            • Nirmal Kumar Ganguly

              Non Executive Director

          • Included In

            • BSE 100

              No

            • BSE 200

              No

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              No

          • Details

            • BSE:

              542919

            • NSE:

              ARTEMISMED

            • Series

              BE

            • ISIN

              INE025R01013

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>